Guardian Capital (Canada)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
33,791
+1,492
+5% +$511K 0.3% 68
2026
Q1
$11.4M Buy
32,299
+7,522
+30% +$2.68M 0.3% 71
2025
Q4
$8.11M Sell
24,777
-589
-2% -$187K 0.24% 68
2025
Q3
$7.16M Buy
25,366
+1,753
+7% +$508K 0.23% 72
2025
Q2
$6.59M Buy
23,613
+500
+2% +$142K 0.23% 70
2025
Q1
$7.2M Sell
23,113
-135
-0.6% -$39.9K 0.28% 69
2024
Q4
$6.06M Buy
23,248
+261
+1% +$77.4K 0.23% 74
2024
Q3
$7.41M Sell
22,987
-132
-0.6% -$43.2K 0.27% 65
2024
Q2
$7.22M Buy
23,119
+30
+0.1% +$8.81K 0.27% 64
2024
Q1
$6.56M Sell
23,089
-138
-0.6% -$40.4K 0.23% 65
2023
Q4
$6.69M Sell
23,227
-235
-1% -$64K 0.24% 67
2023
Q3
$6.31M Sell
23,462
-3,665
-14% -$915K 0.23% 69
2023
Q2
$6.02M Buy
27,127
+19
+0.1% +$4.41K 0.19% 73
2023
Q1
$6.55M Sell
27,108
-116
-0.4% -$28.5K 0.21% 77
2022
Q4
$7.15M Sell
27,224
-169
-0.6% -$45.3K 0.24% 71
2022
Q3
$6.17M Buy
+27,393
New +$6.64M 0.21% 71
2020
Q3
Sell
-965
Closed -$228K 154
2020
Q2
$228K Buy
+965
New +$220K 0.01% 145
2020
Q1
Sell
-1,099
Closed -$265K 145
2019
Q4
$265K Sell
1,099
-8
-0.7% -$1.76K 0.01% 156
2019
Q3
$214K Sell
1,107
-89,430
-99% -$17.2M ﹤0.01% 159
2019
Q2
$16.7M Buy
90,537
+23,830
+36% +$4.27M 0.32% 58
2019
Q1
$12.7M Sell
66,707
-4,891
-7% -$934K 0.23% 63
2018
Q4
$13.9M Buy
71,598
+12,994
+22% +$2.54M 0.29% 60
2018
Q3
$12.1M Sell
58,604
-1,157
-2% -$228K 0.2% 67
2018
Q2
$11M Sell
59,761
-2,045
-3% -$362K 0.19% 67
2018
Q1
$10.5M Buy
61,806
+10,690
+21% +$1.96M 0.18% 72
2017
Q4
$8.89M Sell
51,116
-557
-1% -$98.6K 0.13% 84
2017
Q3
$9.63M Sell
51,673
-534
-1% -$94.6K 0.14% 89
2017
Q2
$8.99M Sell
52,207
-7,153
-12% -$1.16M 0.14% 92
2017
Q1
$9.74M Sell
59,360
-1,739
-3% -$289K 0.15% 88
2016
Q4
$8.93M Sell
61,099
-625
-1% -$94.1K 0.13% 91
2016
Q3
$10.3M Buy
61,724
+9,488
+18% +$1.6M 0.16% 78
2016
Q2
$7.95M Sell
52,236
-3,833
-7% -$596K 0.13% 88
2016
Q1
$8.41M Sell
56,069
-14,347
-20% -$2.13M 0.14% 84
2015
Q4
$11.4M Buy
70,416
+9,475
+16% +$1.49M 0.22% 69
2015
Q3
$8.43M Buy
60,941
+55,858
+1,099% +$8.8M 0.16% 72
2015
Q2
$780K Buy
5,083
+2,221
+78% +$356K 0.01% 147
2015
Q1
$457K Buy
2,862
+514
+22% +$81K 0.01% 162
2014
Q4
$374K Sell
2,348
-7,616
-76% -$1.19M 0.01% 197
2014
Q3
$1.4M Buy
9,964
+6,181
+163% +$807K 0.02% 125
2014
Q2
$448K Sell
3,783
-8,347
-69% -$966K 0.01% 176
2014
Q1
$1.5M Buy
12,130
+6,470
+114% +$785K 0.02% 123
2013
Q4
$646K Sell
5,660
-6,270
-53% -$713K 0.01% 152
2013
Q3
$1.33M Buy
11,930
+1,750
+17% +$190K 0.02% 128
2013
Q2
$1M Buy
+10,180
New +$1.06M 0.02% 134

Other funds holding AMGN

Guardian Capital (Canada)'s AMGN Position: Q2 2026 in Review

Guardian Capital (Canada) increased its Amgen (AMGN) stake by 4.6% in Q2 2026, buying an estimated $511K and bringing the position to 33,791 shares worth $12.2M. The position accounts for 0.3% of the portfolio, ranked #68.

Guardian Capital (Canada) first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $16.7M in Q2 2019. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Guardian Capital (Canada) held 33,791 shares of Amgen worth $12.2M as of Q2 2026.
  • Guardian Capital (Canada) bought 1,492 Amgen shares in Q2 2026, an estimated $511K.
  • Amgen made up 0.3% of Guardian Capital (Canada)'s portfolio in Q2 2026, its #68 holding.
  • Guardian Capital (Canada) first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
  • Guardian Capital (Canada)'s Amgen position peaked at $16.7M in Q2 2019.
  • 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.